Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Caredx Inc (NASDAQ: CDNA) closed at $17.62 in the last session, down -3.29% from day before closing price of $18.22. In other words, the price has decreased by -$3.29 from its previous closing price. On the day, 0.54 million shares were traded. CDNA stock price reached its highest trading level at $18.24 during the session, while it also had its lowest trading level at $17.56.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.94. For the most recent quarter (mrq), Quick Ratio is recorded 3.72 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 07 ’25 when Jain Abhishek sold 265 shares for $17.72 per share. The transaction valued at 4,696 led to the insider holds 337,418 shares of the business.
Novack Jeffrey Adam sold 924 shares of CDNA for $16,373 on Apr 07 ’25. The Secretary and General Counsel now owns 126,911 shares after completing the transaction at $17.72 per share. On Mar 10 ’25, another insider, Bickerstaff George, who serves as the Director of the company, sold 20,000 shares for $18.36 each. As a result, the insider received 367,102 and left with 103,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1009860416 and an Enterprise Value of 744317312. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.93 while its Price-to-Book (P/B) ratio in mrq is 2.55. Its current Enterprise Value per Revenue stands at 2.23 whereas that against EBITDA is -18.816.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.18, which has changed by 1.120337 over the last 52 weeks, in comparison to a change of 0.0635103 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $7.42. The 50-Day Moving Average of the stock is -12.00%, while the 200-Day Moving Average is calculated to be -24.40%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 811.96K shares per day over the past 3-months and 763150 shares per day over the past 10 days. A total of 54.77M shares are outstanding, with a floating share count of 51.51M. Insiders hold about 7.06% of the company’s shares, while institutions hold 100.39% stake in the company. Shares short for CDNA as of 1743379200 were 5555960 with a Short Ratio of 6.84, compared to 1740700800 on 5177711. Therefore, it implies a Short% of Shares Outstanding of 5555960 and a Short% of Float of 13.08.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
